Next Article in Journal
Endocytosis of Corn Oil-Caseinate Emulsions In Vitro: Impacts of Droplet Sizes
Previous Article in Journal
Impact of 3–Aminopropyltriethoxysilane-Coated Iron Oxide Nanoparticles on Menaquinone-7 Production Using B. subtilis
Previous Article in Special Issue
Nanometric MIL-125-NH2 Metal–Organic Framework as a Potential Nerve Agent Antidote Carrier
Article Menu
Issue 11 (November) cover image

Export Article

Open AccessFeature PaperArticle
Nanomaterials 2017, 7(11), 351;

Liposome-Coated Iron Fumarate Metal-Organic Framework Nanoparticles for Combination Therapy

Department of Chemistry and Center for NanoScience (CeNS), LMU Munich, Butenandtstraße 11 (E), 81377 Munich, Germany
School of Chemistry, Joseph Banks Laboratories, University of Lincoln, Lincoln LN67TS, UK
Authors to whom correspondence should be addressed.
Received: 17 August 2017 / Revised: 16 October 2017 / Accepted: 20 October 2017 / Published: 26 October 2017
(This article belongs to the Special Issue Nanoparticles in Metal-Organic Frameworks)
Full-Text   |   PDF [1618 KB, uploaded 26 October 2017]   |  


One of the main problems for effective treatment of cancer is resistances, which often require combination therapy—for effective treatment. While there are already some potential drug carriers—e.g., liposomes, available for treatment—the effective loading and retention of the desired drug ratio can be challenging. To address this challenge, we propose a new type of drug carrier: liposome-coated metal-organic framework (MOF) nanoparticles. They combine the advantages of liposomes with an easy and efficient loading process. In this work, we present the successful synthesis of liposome-coated MOF nanoparticles via the fusion method. The resulting particles, once loaded, show no premature leakage and an efficient release. Their successful loading with both single and multiple drugs at the same time makes them an interesting candidate for use in combination therapy. View Full-Text
Keywords: metal-organic framework; nanoparticles; drug delivery; combination therapy metal-organic framework; nanoparticles; drug delivery; combination therapy

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Supplementary material


Share & Cite This Article

MDPI and ACS Style

Illes, B.; Wuttke, S.; Engelke, H. Liposome-Coated Iron Fumarate Metal-Organic Framework Nanoparticles for Combination Therapy. Nanomaterials 2017, 7, 351.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Nanomaterials EISSN 2079-4991 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top